Campbell's Company (The) (CPB)
NASDAQConsumer StaplesPackaged FoodsSnapshot 2026-07-09
$21.47-2.36%
Close 2026-07-09 · 1-day change
Reading CPB? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track CPB free→NASDAQConsumer StaplesPackaged FoodsSnapshot 2026-07-09
Reading CPB? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track CPB free→QuarterlyIQ Insights · CPB
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 13 valuation methods, at three horizons. Current price $21.47. As of 2026-07-09. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A long-thesis check that carries the widest uncertainty of the three horizons.
Below average on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $22 CPB trades at 9.2× p/e, below its 13× p/e peer median. Our $24 fair value sits above the price. It's a high-confidence read. Analysts target $17–$24. Note: our $24 fair value sits above the entire analyst range ($17–$24). Not investment advice.
$17.00 – $24.00 (median $20.00) · 17 analysts · as of 2026-06-09
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
No fragility gates fired. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
These describe the expectations embedded in the price, not a forecast of the move. Reverse-DCF base: $1.87/sh owner earnings.
Looks cheaper than most peers in the same business.
Cheaper than its own typical valuation.
Trailing four: 2025-Q3, 2026-Q1, 2026-Q2, 2026-Q3
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $20.00 | — | — | Analyst | high |
| dcf fcfe | 12M | $27.45 | — | — | Hist. CAGR | high |
| dcf fcff | 12M | $20.97 | — | — | Hist. CAGR | high |
| ddm gordon | 12M | $14.08 | — | — | TTM | high |
| graham number | 12M | $26.98 | — | — | TTM | high |
| Mgmt guidance | 12M | $32.84 | 13.3 | 2.48 | Mgmt | high |
| Peer EV/EBITDA | 12M | $25.24 | 9.9 | 4.76 | TTM | high |
| Peer P/FCF | 12M | $26.18 | 12.2 | 2.15 | TTM | high |
| Peer P/E | 12M | $31.84 | 13.3 | 2.40 | TTM | high |
| Peer P/S | 12M | $30.08 | 0.9 | 34.29 | TTM | high |
| residual income | 12M | $17.89 | — | — | TTM | high |
| Own P/E history | 12M | $25.43 | 10.6 | 2.40 | TTM | high |
| triangulated | 12M | $32.31 | 13.3 | 2.44 | Triangulated | high |
| Mgmt guidance | 3Y | $18.89 | 13.3 | 1.42 | Mgmt(prov.) | medium |
| Peer P/FCF | 3Y | $24.87 | 12.2 | 2.05 | Hist. CAGR(prov.) | medium |
| Peer P/E | 3Y | $35.32 | 13.3 | 2.66 | Analyst | medium |
| Peer P/S | 3Y | $26.30 | 0.9 | 29.99 | Analyst | medium |
| Own P/E history | 3Y | $28.21 | 10.6 | 2.66 | Analyst | medium |
| Mgmt guidance | 5Y | $13.06 | 13.3 | 0.98 | Mgmt(prov.) | high |
| Peer P/FCF | 5Y | $24.03 | 12.2 | 1.98 | Hist. CAGR(prov.) | high |
| Peer P/E | 5Y | $32.30 | 13.3 | 2.43 | Analyst | high |
| Peer P/S | 5Y | $24.06 | 0.9 | 27.43 | Analyst | high |
| Own P/E history | 5Y | $25.80 | 10.6 | 2.43 | Analyst | high |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.